Last reviewed · How we verify
chronic plaque psoriasis
Approved treatments
Clinical guidelines
- FDA label — 1L|2L
Treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- chronic plaque psoriasis patent landscape — cliff calendar, originator estates, attackable patents
- chronic plaque psoriasis treatment landscape brief
- chronic plaque psoriasis treatment updates RSS
Frequently asked questions about chronic plaque psoriasis
What are the treatment guidelines for chronic plaque psoriasis?
FDA label publishes guidelines for chronic plaque psoriasis. 1 guideline references tracked.
Related
- Treatment landscape: chronic plaque psoriasis patent cliff · chronic plaque psoriasis CI report
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing